2-phenylethyl isocyanate | CAS:1943-82-4

We serve 2-phenylethyl isocyanate CAS:1943-82-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-phenylethyl isocyanate

Chemical Name:2-phenylethyl isocyanate
CAS.NO:1943-82-4
Synonyms:2-phenylethyl isocyanate
Phenethyl Isocyanate
Phenylethyl isocyanate
2-Phenylethyl Isocyanate
2-phenethylisocyanate
2-Phenylethylisocyanate
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 228.5±19.0 °C at 760 mmHg
Molecular Formula C9H9NO
Molecular Weight 147.174
Flash Point 67.4±22.6 °C
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Glimpiride



Contact us for information like 2-phenylethyl isocyanate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Phenylethylisocyanate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-phenethylisocyanate Use and application,2-Phenylethylisocyanate technical grade,usp/ep/jp grade.


Related News: South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak.2-Isopropylphenol manufacturer The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.Dibutyl sulfide supplier There are also new directives that relate to US citizens.2-(4,5-Bis(benzyloxy)-2-nitrophenyl)acetonitrile vendor According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.